文献速递免疫规划卫生政策与健康促进

香港65岁及以上人群肺炎球菌疫苗接种意愿调查

Acceptance of pneumococcal vaccination in older adults: A general population-based survey.
PubMed 文献 · Vaccine · 2021-10-25

该研究基于健康信念模型在香港65岁及以上普通人群中开展电话调查,共纳入1000名受访者,其中402人(40.2%)有意在未来12个月内参加政府疫苗接种计划。政府或医生推荐、感知易感性高、自我效能高等因素与接种意愿独立相关,提示接种接受率仍不理想。

要点

  • 40.2%的65岁及以上受访者有意在12个月内参加政府肺炎球菌疫苗接种计划。
  • 政府推荐(aOR=8.025)与医生推荐(aOR=7.399)与接种意愿的关联最强。
  • 提升感知益处与自我效能、减少接种障碍是促进接种的关键方向。

核心结论

  • 香港65岁及以上人群对肺炎球菌疫苗接种计划的接受率仍不理想,政府和医生应参与推广并提升感知益处与自我效能。

研究设计与样本

  • 基于普通人群的电话调查,采用简单随机抽样,对象为65岁及以上公众,使用基于健康信念模型(HBM)的经验证问卷,共纳入1000名受访者。
  • 采用二元逻辑回归模型分析与接种意愿独立相关的因素。

主要发现

  • 1000名受访者中402人(40.2%)有意在未来12个月内参加政府疫苗接种计划(GVP/VSS)。
  • 有长期就医和用药者接种意愿更高(aOR=1.541,95%CI:1.008-2.356,p=0.046)。
  • 感知感染易感性高者接种意愿更高(aOR=3.624,95%CI:2.318-5.665,p<0.001)。
  • 感知疫苗益处高者接种意愿更高(aOR=1.699,95%CI:1.153-2.504,p<0.001)。
  • 政府推荐(aOR=8.025,95%CI:4.771-13.497,p<0.001)或医生推荐(aOR=7.399,95%CI:3.472-15.764,p=0.008)及自我效能高(aOR=3.045,95%CI:1.458-6.362,p=0.003)者接种意愿更高。

临床怎么用

  • 在老年人群肺炎球菌疫苗接种推广中,应强化政府与医生的主动推荐,并针对感知益处、自我效能和接种障碍开展健康教育。

局限性

  • 研究结论需在其他环境中进一步研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pneumococcal infection is a leading cause of disability and death globally. The Hong Kong Government has launched two programmes for pneumococcal vaccination - The Vaccination Subsidy Scheme (VSS) and the Government Vaccination Programme (GVP). This study aimed to examine the enabling factors, obstacles and perception of pneumococcal vaccination, and their association with its uptake in a general Chinese population. METHODS: We performed a population-based, telephone survey in the general public aged 65 or above via simple random sampling. A validated survey based on the Health Belief Model (HBM) was used. Their socio-demographic information; history of previous participation in the GVP or VSS; and self-perceived health status were captured. Binary logistic regression models were constructed to examine the factors independently associated with vaccination. RESULTS: A total of 1,000 respondents were enrolled in the study, with 402 (40.2%) respondents having intention to join the GVP/VSS in 12 months. Respondents with long-term medical consultant and medication (adjusted odds ratios [aOR] = 1.541, 95% confidence interval (CI): 1.008-2.356, p = 0.046); high levels of perceived susceptibility of infections (aOR = 3.624, 95 %CI: 2.318-5.665, p < 0.001); high levels of perceived benefits of vaccine (aOR = 1.699, 95 %CI: 1.153-2.504, p < 0.001); recommendations from government (aOR = 8.025, 95 %CI: 4.771-13.497, p < 0.001) or physicians (aOR = 7.399, 95 %CI: 3.472-15.764, p = 0.008); and high levels of self-efficacy (aOR = 3.045, 95 %CI: 1.458-6.362, p = 0.003) were more likely to have intention to participate in the vaccination programme. CONCLUSIONS: The acceptance rate of pneumococcal vaccination programme remained suboptimal in the population. The government and physicians should be involved in the promotion of pneumococcal vaccination and GVP/VSS by increasing perceived benefits and self-efficacy, and reducing barriers towards vaccination among the target population. More studies are required to confirm our findings in other settings.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Huang J, Bai Y, Ding H, et al. Acceptance of pneumococcal vaccination in older adults: A general population-based survey. Vaccine. 2021. PMID: 34711437. doi:10.1016/j.vaccine.2021.10.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。